Company intelligence / Profile preview

OnDosis

Gothenburg, Västra Götaland County, Swedenondosis.com ↗

Ownership: Private
Development stage: Preclinical

Overview

OnDosis has developed and commercialized an intelligent handheld device that enables flexible and individualized dosing of oral solid medicines. The company collaborates with pharmaceutical partners to integrate its technology into new drugs or value-added generics. Clinical results are dependent on partner programs; the platform itself has been validated in feasibility studies and co-development projects.

Therapeutic areas: PsychiatryImmunologyNeurology
Modalities: DeviceDigital health solutionDrug delivery system (for oral solids such as granules, pellets, powders, mini tablets)
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with leading pharmaceutical companies for co-development and outlicensing of the device/drug combination technology. Specific partner names not disclosed publicly.

Beyond the preview

Go deeper on OnDosis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OnDosis.